These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21757189)

  • 1. Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity.
    Lei J; Wang Z; Hui D; Yu W; Zhou D; Xia W; Chen C; Zhang Q; Wang Z; Zhang Q; Xiang AP
    Cell Immunol; 2011; 271(1):147-56. PubMed ID: 21757189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
    Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
    Opitz CA; Litzenburger UM; Lutz C; Lanz TV; Tritschler I; Köppel A; Tolosa E; Hoberg M; Anderl J; Aicher WK; Weller M; Wick W; Platten M
    Stem Cells; 2009 Apr; 27(4):909-19. PubMed ID: 19353519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation.
    Sioud M; Mobergslien A; Boudabous A; Fløisand Y
    Scand J Immunol; 2010 Apr; 71(4):267-74. PubMed ID: 20384870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
    Ye Z; Wang Y; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in TLR2 but not in TLR4 impairs dendritic cells derived IL-10 responses to schistosome antigens.
    Gao Y; Zhang M; Chen L; Hou M; Ji M; Wu G
    Cell Immunol; 2012; 272(2):242-50. PubMed ID: 22063738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
    English K; Barry FP; Field-Corbett CP; Mahon BP
    Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.
    Raicevic G; Najar M; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Cell Immunol; 2011; 270(2):207-16. PubMed ID: 21700275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
    Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
    Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression.
    Nasef A; Mazurier C; Bouchet S; François S; Chapel A; Thierry D; Gorin NC; Fouillard L
    Cell Immunol; 2008; 253(1-2):16-22. PubMed ID: 18639869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect.
    Choi YS; Jeong JA; Lim DS
    Immunol Invest; 2012; 41(2):214-29. PubMed ID: 22017637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
    Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
    Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
    Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
    Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop.
    Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR
    J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia.
    Zhao ZG; Xu W; Sun L; Li WM; Li QB; Zou P
    Eur J Cancer; 2012 Aug; 48(12):1884-95. PubMed ID: 22129888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFNβ produced by TLR4-activated tumor cells is involved in improving the antitumoral immune response.
    Núñez NG; Andreani V; Crespo MI; Nocera DA; Breser ML; Morón G; Dejager L; Libert C; Rivero V; Maccioni M
    Cancer Res; 2012 Feb; 72(3):592-603. PubMed ID: 22139376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.